Thus, examining T cell expansion and SKWX301 binding dynamics in tumors treated with SKWX301 will be a critical next step to decipher the functional ramifications of the SKWX301-TIM-4 interaction and better understand how SKWX301 acts in the tumor microenvironment to potentiate immunotherapy. This evidence concerns the gene TIMD4 and neoplasm.